{"id":1189,"date":"2026-10-04T18:57:33","date_gmt":"2026-10-04T18:57:33","guid":{"rendered":"https:\/\/muhammetozgehan.com\/sopk-syndrome-des-ovaires-polykystiques-et-alopecie\/"},"modified":"2026-10-08T21:33:21","modified_gmt":"2026-10-08T21:33:21","slug":"sopk-syndrome-des-ovaires-polykystiques-et-alopecie","status":"publish","type":"page","link":"https:\/\/muhammetozgehan.com\/fr\/sopk-syndrome-des-ovaires-polykystiques-et-alopecie\/","title":{"rendered":"SOPK (Syndrome des Ovaires Polykystiques) et Alop\u00e9cie"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1189\" class=\"elementor elementor-1189 elementor-348\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9b0f101 e-flex e-con-boxed e-con e-parent\" data-id=\"9b0f101\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-996b7d9 elementor-widget elementor-widget-html\" data-id=\"996b7d9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<div class=\"medical-guide-page-wrapper\">\r\n    <!-- Sayfa \u00dcst\u00fc K\u00fcresel Ba\u015fl\u0131k & Logo Alan\u0131 -->\r\n    <div class=\"guide-hero\">\r\n        <div class=\"hero-title-wrapper\">\r\n            <div class=\"hero-logo-box\">\r\n                <img decoding=\"async\" src=\"https:\/\/muhammetozgehan.com\/wp-content\/uploads\/2026\/10\/logo-seffaf.png\" alt=\"Logo du Dr Muhammet \u00d6zgehan\" width=\"32\" height=\"32\" class=\"hero-inline-logo\" title=\"\">\r\n            <\/div>\r\n            <h2>Encyclop\u00e9die M\u00e9dicale Capillaire<\/h2>\r\n        <\/div>\r\n        <p class=\"guide-subtitle\">Pathologies dermatologiques et guides cliniques fond\u00e9s sur des preuves, selon les normes internationales.<\/p>\r\n    <\/div>\r\n\r\n    <!-- Ana Makale Konteyneri -->\r\n    <article class=\"medical-article-card\">\r\n        <div class=\"article-header\">\r\n            <span class=\"article-category\">GUIDE CLINIQUE & PATHOLOGIE<\/span>\r\n            <h1>SOPK (Syndrome des Ovaires Polykystiques) et Alop\u00e9cie<\/h1>\r\n            <div class=\"author-meta-box\">\r\n                <p><strong>Pr\u00e9par\u00e9 par :<\/strong> Dr. Muhammet \u00d6zgehan | Association Turque des Maladies des Cheveux et du Cuir Chevelu<\/p>\r\n                <p class=\"compilation-note\"><em>Ce guide a \u00e9t\u00e9 compil\u00e9 par le Dr Muhammet \u00d6zgehan, en se basant sur la litt\u00e9rature actuelle.<\/em><\/p>\r\n            <\/div>\r\n        <\/div>\r\n\r\n        <!-- 1. Birinci G\u00f6rsel: Genel Klinik Bulgular -->\r\n        <div class=\"medical-illustration-box\">\r\n            <img decoding=\"async\" src=\"https:\/\/sachastaliklari.org.tr\/wp-content\/uploads\/2026\/09\/polikistik-over-sendromu-pcos-klinik-bulgular-dr-muhammet-ozgehan.png\" alt=\"Illustration des Manifestations Cliniques du SOPK\" title=\"\">\r\n            <p class=\"illustration-caption\">Figure 1 : R\u00e9percussions syst\u00e9miques du Syndrome des Ovaires Polykystiques (SOPK) sur les cheveux et la peau.<\/p>\r\n        <\/div>\r\n\r\n        <!-- Ge\u00e7i\u015f Metni -->\r\n        <div class=\"transition-banner\">\r\n            <h3>\u00c9quilibre Hormonal et Effets sur le Follicule Pileux<\/h3>\r\n            <p>Le Syndrome des Ovaires Polykystiques (SOPK) n'est pas seulement un probl\u00e8me du syst\u00e8me reproducteur ; il s'agit d'un tableau syst\u00e9mique affectant l'ensemble du m\u00e9tabolisme corporel et l'\u00e9quilibre endocrinien. Comme r\u00e9sum\u00e9 dans l'illustration ci-dessus, les fluctuations hormonales d'origine ovarienne et les m\u00e9canismes de r\u00e9sistance \u00e0 l'insuline qui les accompagnent ciblent directement les follicules pileux. La diminution de la qualit\u00e9 et l'amincissement (miniaturisation) des cheveux constituent l'un des signes cliniques d'alerte les plus pr\u00e9coces et les plus prononc\u00e9s de cette condition.  <\/p>\r\n        <\/div>\r\n\r\n        <!-- 2. \u0130kinci G\u00f6rsel: Minyat\u00fcrizasyon ve \u0130ns\u00fclin Direnci -->\r\n        <div class=\"medical-illustration-box\">\r\n            <img decoding=\"async\" src=\"https:\/\/sachastaliklari.org.tr\/wp-content\/uploads\/2026\/09\/androgenetik-alopesi-ve-insulin-direnci-minyarurizasyon-dr-muhammet-ozgehan.png\" alt=\"Illustration de la Miniaturisation due \u00e0 l&#039;Alop\u00e9cie Androg\u00e9n\u00e9tique et \u00e0 la R\u00e9sistance \u00e0 l&#039;Insuline\" title=\"\">\r\n            <p class=\"illustration-caption\">Figure 2 : Processus de miniaturisation du follicule pileux induit par la r\u00e9sistance \u00e0 l'insuline et l'hyperandrog\u00e9nie.<\/p>\r\n        <\/div>\r\n\r\n        <!-- Hasta Bilgilendirme B\u00f6l\u00fcm\u00fc -->\r\n        <section class=\"patient-info-box\">\r\n            <h3>\ud83d\udccc Section d'Information pour les Patients : Que Signifie Cette Condition ?<\/h3>\r\n            \r\n            <h4 class=\"sub-heading\">Qu'est-ce que le Syndrome des Ovaires Polykystiques (SOPK) ?<\/h4>\r\n            <p>Le SOPK est une condition hormonale (endocrinienne) caract\u00e9ris\u00e9e par des d\u00e9s\u00e9quilibres hormonaux, fr\u00e9quemment observ\u00e9e chez les femmes en \u00e2ge de procr\u00e9er. Il affecte le fonctionnement des ovaires et de nombreux syst\u00e8mes corporels. <\/p>\r\n\r\n            <h4 class=\"sub-heading\">Le SOPK provoque-t-il la chute des cheveux ?<\/h4>\r\n            <p>Oui. En cas de SOPK, les hormones masculines (androg\u00e8nes) peuvent \u00eatre pr\u00e9sentes \u00e0 des niveaux l\u00e9g\u00e8rement plus \u00e9lev\u00e9s que la normale dans le corps, ou le corps peut devenir plus sensible \u00e0 ces hormones. Cette situation entra\u00eene un affaiblissement des racines capillaires, un amincissement progressif et une chute des cheveux. Elle se manifeste g\u00e9n\u00e9ralement sous la forme d'une \u00ab alop\u00e9cie de type f\u00e9minin \u00bb.   <\/p>\r\n\r\n            <h4 class=\"sub-heading\">Quels sont les autres sympt\u00f4mes du SOPK ?<\/h4>\r\n            <ul class=\"styled-list\">\r\n                <li>Irr\u00e9gularit\u00e9s menstruelles ou am\u00e9norrh\u00e9e<\/li>\r\n                <li>Peau excessivement grasse et acn\u00e9 persistante<\/li>\r\n                <li>Augmentation de la pilosit\u00e9 faciale ou corporelle (hirsutisme)<\/li>\r\n                <li>Difficult\u00e9 \u00e0 perdre du poids et tendance \u00e0 la prise de poids<\/li>\r\n            <\/ul>\r\n\r\n            <h4 class=\"sub-heading\">Que faire ?<\/h4>\r\n            <p>Si votre chute de cheveux est accompagn\u00e9e de certains de ces sympt\u00f4mes, les shampoings ou les produits de soin externes seuls ne suffiront pas. Un plan de traitement interne doit \u00eatre \u00e9labor\u00e9 apr\u00e8s des tests hormonaux, en collaboration avec un dermatologue et un gyn\u00e9cologue. <\/p>\r\n        <\/section>\r\n\r\n        <!-- Hekimler \u0130\u00e7in Klinik K\u0131lavuz -->\r\n        <section class=\"doctor-guide-box\">\r\n            <h3>\ud83e\ude7a Guide Clinique & M\u00e9dical pour les M\u00e9decins<\/h3>\r\n            <p class=\"protocol-title\">Protocole de Trichologie Clinique : Alop\u00e9cie de Type F\u00e9minin (FPHL) associ\u00e9e au SOPK<\/p>\r\n            <ul class=\"styled-list doctor-list\">\r\n                <li><strong>Physiopathologie :<\/strong> L'hyperandrog\u00e9nie d'origine ovarienne et surr\u00e9nalienne augmente la conversion en dihydrotestost\u00e9rone (DHT) dans les tissus p\u00e9riph\u00e9riques via l'enzyme 5-alpha r\u00e9ductase. Cette situation raccourcit la dur\u00e9e de la phase anag\u00e8ne et d\u00e9clenche un cycle de miniaturisation progressive des follicules pileux. <\/li>\r\n                <li><strong>R\u00e9sistance \u00e0 l'Insuline et Relation avec la SHBG :<\/strong> L'hyperinsulin\u00e9mie, fr\u00e9quemment associ\u00e9e aux cas de SOPK, supprime la synth\u00e8se de la Globuline Liant les Hormones Sexuelles (SHBG) dans le foie. Ce m\u00e9canisme augmente le rapport de testost\u00e9rone libre et biologiquement active en circulation, acc\u00e9l\u00e9rant ainsi les dommages folliculaires. <\/li>\r\n                <li><strong>Approche Diagnostique et Examen de Laboratoire :<\/strong> Niveaux s\u00e9riques de testost\u00e9rone totale\/libre, DHEAS, rapport LH\/FSH, 17-OH progest\u00e9rone, prolactine et d\u00e9pistage m\u00e9tabolique (glyc\u00e9mie \u00e0 jeun, HbA1c, HOMA-IR). Constatations trichoscopiques : atrophie focale, variabilit\u00e9 du diam\u00e8tre des cheveux sup\u00e9rieure \u00e0 20 % (miniaturisation) et signes p\u00e9rifolliculaires. <\/li>\r\n                <li><strong>Modalit\u00e9s Th\u00e9rapeutiques Fond\u00e9es sur des Preuves :<\/strong> Modulation du mode de vie, am\u00e9lioration de la sensibilit\u00e9 \u00e0 l'insuline, agents antiandrog\u00e8nes, sensibilisateurs \u00e0 l'insuline (d\u00e9riv\u00e9s de metformine\/inositol), minoxidil topique (5 %) et approches proc\u00e9durales adjuvantes (PRP\/microneedling). De plus, pour les \u00e9valuations cliniques et chirurgicales, les <a href=\"https:\/\/www.muhammetozgehan.com.tr\" target=\"_blank\" rel=\"noopener\">approches sp\u00e9cialis\u00e9es et th\u00e9rapeutiques<\/a> peuvent \u00eatre examin\u00e9es. <\/li>\r\n            <\/ul>\r\n        <\/section>\r\n\r\n        <!-- Bilimsel Referanslar -->\r\n        <section class=\"scientific-references-box\">\r\n            <h3>R\u00e9f\u00e9rences Scientifiques et Bibliographie<\/h3>\r\n            <ul class=\"ref-list\">\r\n                <li>Rashid R, Mir SA, Kareem O, Ali T, Ara R, Malik A, Amin F, Bader GN. Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. <em>Taiwan J Obstet Gynecol.<\/em> 2022 Jan;61(1):40-50. doi: 10.1016\/j.tjog.2021.11.009. PMID: 35181044. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35181044\/\" target=\"_blank\" rel=\"noopener\">Lien PubMed<\/a> <\/li>\r\n                <li>Mavulati SC, Dodoala S. Clinical Profile of Polycystic Ovarian Syndrome in Women From Bhimavaram: A Cross-Sectional Study. <em>Cureus.<\/em> 2025 Apr 7;17(4):e81854. doi: 10.7759\/cureus.81854. PMID: 40342475; PMCID: PMC12059241. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40342475\/\" target=\"_blank\" rel=\"noopener\">Lien PubMed<\/a><\/li>\r\n                <li>Kolhe JV, Chhipa AS, Butani S, Chavda V, Patel SS. PCOS and Depression: Common Links and Potential Targets. <em>Reprod Sci.<\/em> 2022 Nov;29(11):3106-3123. doi: 10.1007\/s43032-021-00765-2. Epub 2021 Oct 12. PMID: 34642910. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34642910\/\" target=\"_blank\" rel=\"noopener\">Lien PubMed<\/a> <\/li>\r\n                <li>Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. <em>Nat Rev Dis Primers.<\/em> 2016 Aug 11;2:16057. doi: 10.1038\/nrdp.2016.57. PMID: 27510637. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27510637\/\" target=\"_blank\" rel=\"noopener\">Lien PubMed<\/a> <\/li>\r\n            <\/ul>\r\n        <\/section>\r\n    <\/article>\r\n<\/div>\r\n\r\n<style>\r\n.medical-guide-page-wrapper {\r\n    background-color: #0A192F;\r\n    padding: 60px 20px;\r\n    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;\r\n    color: #FFFFFF;\r\n    max-width: 1000px;\r\n    margin: 0 auto;\r\n}\r\n\r\n.guide-hero {\r\n    text-align: center;\r\n    margin-bottom: 40px;\r\n}\r\n\r\n.hero-title-wrapper {\r\n    display: flex;\r\n    align-items: center;\r\n    justify-content: center;\r\n    gap: 12px;\r\n    margin-bottom: 10px;\r\n}\r\n\r\n.hero-logo-box {\r\n    background: linear-gradient(135deg, rgba(17, 34, 64, 0.9), rgba(10, 25, 47, 0.95));\r\n    border: 1px solid rgba(212, 175, 55, 0.4);\r\n    border-radius: 8px;\r\n    padding: 4px 8px;\r\n    display: flex !important;\r\n    align-items: center !important;\r\n    justify-content: center !important;\r\n    width: 44px !important;\r\n    height: 44px !important;\r\n    box-shadow: 0 4px 15px rgba(0,0,0,0.3);\r\n    flex-shrink: 0;\r\n}\r\n\r\n.hero-inline-logo {\r\n    width: 32px !important;\r\n    height: 32px !important;\r\n    max-width: 32px !important;\r\n    max-height: 32px !important;\r\n    object-fit: contain !important;\r\n}\r\n\r\n.guide-subtitle {\r\n    color: #CBD5E1;\r\n    font-size: 15px;\r\n    margin: 0;\r\n}\r\n\r\n.medical-article-card {\r\n    background: linear-gradient(135deg, rgba(17, 34, 64, 0.85), rgba(10, 25, 47, 0.95));\r\n    border: 1px solid rgba(212, 175, 55, 0.3);\r\n    border-radius: 16px;\r\n    padding: 40px;\r\n    box-shadow: 0 10px 30px rgba(0,0,0,0.4);\r\n}\r\n\r\n.article-header {\r\n    border-bottom: 1px solid rgba(212, 175, 55, 0.2);\r\n    padding-bottom: 25px;\r\n    margin-bottom: 30px;\r\n}\r\n\r\n.article-category {\r\n    display: inline-block;\r\n    color: #D4AF37;\r\n    font-size: 10px;\r\n    font-weight: 700;\r\n    text-transform: uppercase;\r\n    letter-spacing: 2px;\r\n    background: rgba(212, 175, 55, 0.1);\r\n    padding: 4px 10px;\r\n    border-radius: 4px;\r\n    margin-bottom: 15px;\r\n}\r\n\r\n.medical-article-card h1 {\r\n    font-size: 28px;\r\n    color: #FFFFFF;\r\n    margin: 0 0 15px 0;\r\n    font-weight: 700;\r\n    line-height: 1.3;\r\n}\r\n\r\n.author-meta-box p {\r\n    font-size: 14px;\r\n    color: #CBD5E1;\r\n    margin: 3px 0;\r\n}\r\n\r\n.compilation-note {\r\n    color: #94A3B8;\r\n    font-size: 13px;\r\n}\r\n\r\n.medical-illustration-box {\r\n    margin: 30px 0;\r\n    text-align: center;\r\n    background: rgba(0, 0, 0, 0.2);\r\n    padding: 15px;\r\n    border-radius: 10px;\r\n    border: 1px solid rgba(255, 255, 255, 0.05);\r\n}\r\n\r\n.medical-illustration-box img {\r\n    max-width: 100%;\r\n    height: auto;\r\n    border-radius: 8px;\r\n    box-shadow: 0 4px 15px rgba(0,0,0,0.3);\r\n}\r\n\r\n.illustration-caption {\r\n    font-size: 13px;\r\n    color: #94A3B8;\r\n    margin-top: 10px;\r\n    font-style: italic;\r\n}\r\n\r\n.transition-banner {\r\n    background: rgba(10, 25, 47, 0.6);\r\n    border-left: 4px solid #D4AF37;\r\n    padding: 20px;\r\n    border-radius: 0 10px 10px 0;\r\n    margin: 30px 0;\r\n    border-top: 1px solid rgba(212, 175, 55, 0.2);\r\n    border-right: 1px solid rgba(212, 175, 55, 0.2);\r\n    border-bottom: 1px solid rgba(212, 175, 55, 0.2);\r\n}\r\n\r\n.transition-banner h3 {\r\n    color: #D4AF37;\r\n    margin-top: 0;\r\n    font-size: 16px;\r\n    font-weight: 600;\r\n}\r\n\r\n.transition-banner p {\r\n    margin-bottom: 0;\r\n    color: #CBD5E1;\r\n    font-size: 14px;\r\n    line-height: 1.6;\r\n}\r\n\r\n.patient-info-box, .doctor-guide-box, .scientific-references-box {\r\n    margin-top: 35px;\r\n    background: rgba(10, 25, 47, 0.6);\r\n    border: 1px solid rgba(212, 175, 55, 0.2);\r\n    border-radius: 12px;\r\n    padding: 25px;\r\n}\r\n\r\n.medical-article-card h3 {\r\n    font-size: 18px;\r\n    color: #D4AF37;\r\n    margin-top: 0;\r\n    margin-bottom: 15px;\r\n    font-weight: 600;\r\n}\r\n\r\n.sub-heading {\r\n    font-size: 15px;\r\n    color: #FFFFFF;\r\n    margin-top: 20px;\r\n    margin-bottom: 8px;\r\n    font-weight: 600;\r\n}\r\n\r\n.medical-article-card p, .medical-article-card li {\r\n    font-size: 14px;\r\n    color: #CBD5E1;\r\n    line-height: 1.6;\r\n}\r\n\r\n.protocol-title {\r\n    font-weight: 600;\r\n    color: #E2E8F0;\r\n    margin-bottom: 15px;\r\n}\r\n\r\n.styled-list {\r\n    padding-left: 20px;\r\n    margin: 10px 0;\r\n}\r\n\r\n.styled-list li {\r\n    margin-bottom: 10px;\r\n}\r\n\r\n.scientific-references-box {\r\n    border-top: 1px solid rgba(212, 175, 55, 0.3);\r\n}\r\n\r\n.ref-list {\r\n    padding-left: 20px;\r\n    font-size: 13px;\r\n    color: #94A3B8;\r\n}\r\n\r\n.ref-list li {\r\n    margin-bottom: 12px;\r\n}\r\n\r\n.medical-article-card a {\r\n    color: #D4AF37;\r\n    text-decoration: underline;\r\n    transition: color 0.3s ease;\r\n}\r\n\r\n.medical-article-card a:hover {\r\n    color: #f3d06c;\r\n}\r\n\r\n\/* Mobil Uyumluluk *\/\r\n@media (max-width: 768px) {\r\n    .medical-article-card {\r\n        padding: 20px;\r\n    }\r\n    .medical-article-card h1 {\r\n        font-size: 22px;\r\n    }\r\n}\r\n<\/style>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Encyclop\u00e9die M\u00e9dicale Capillaire Pathologies dermatologiques et guides cliniques fond\u00e9s sur des preuves, selon les normes internationales. GUIDE CLINIQUE &#038; PATHOLOGIE SOPK (Syndrome des Ovaires Polykystiques) et Alop\u00e9cie Pr\u00e9par\u00e9 par : Dr. Muhammet \u00d6zgehan | Association Turque des Maladies des Cheveux et du Cuir Chevelu Ce guide a \u00e9t\u00e9 compil\u00e9 par le Dr Muhammet \u00d6zgehan, en [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1189","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/pages\/1189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/comments?post=1189"}],"version-history":[{"count":0,"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/pages\/1189\/revisions"}],"wp:attachment":[{"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/media?parent=1189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}